SCHEMBL6945132

SCHEMBL6945132

COC(=O)C(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KLK5 Q9Y337 3/20 0.68
PSEN1 P49768 7/20 0.57
PSEN2 P49810 7/20 0.57
APH1B Q8WW43 7/20 0.57
NCSTN Q92542 7/20 0.57
APH1A Q96BI3 7/20 0.57
PSENEN Q9NZ42 7/20 0.57
ATM Q13315 1/20 0.55
CTSS P25774 3/20 0.53
CTSK P43235 2/20 0.53
CTSL P07711 1/20 0.53
CTSB P07858 1/20 0.53
ACE P12821 1/20 0.51
TRPM8 Q7Z2W7 1/20 0.50
PYGL P06737 1/20 0.49
APP P05067 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6813547 1.00 KLK5 (0.68) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL6945136 1.00 KLK5 (0.68) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL6578313 0.90 KLK5 (0.59) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL1612669 0.90 KLK5 (0.59) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL3447452 0.89 KLK5 (0.61) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL5650822 0.89 KLK5 (0.61) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL743357 0.89 KLK5 (0.61) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL15775826 0.89 KLK5 (0.61) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL288838 0.89 KLK5 (0.61) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL7356486 0.89 KLK5 (0.61) KLK5PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3788031-B1 DIPEPTIDYL KETOAMIDE META-METHOXYPHENYL DERIVATIVES AND USES THEREOF LANDSTEINER GENMED S L (ES) 2023-09-27 EP disclosed
US-11242312-B2 Dipeptidyl ketoamide meta-methoxyphenyl derivatives and uses thereof LANDSTEINER GENMED, S.L. (ES) 2022-02-08 US disclosed
US-20210317075-A1 DIPEPTIDYL KETOAMIDE META-METHOXYPHENYL DERIVATIVES AND USES THEREOF LANDSTEINER GENMED, S.L. (ES) 2021-10-14 US disclosed
US-20210009564-A1 CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF BLADE THERAPERTICS INC (US) 2021-01-14 US disclosed
EP-3564211-A1 DIPEPTIDYL KETOAMIDE META-METHOXYPHENYL DERIVATIVES AND USES THEREOF LANDSTEINER GENMED, S.L. (ES) 2019-11-06 EP disclosed
EP-0827943-B1 PROCESSES FOR THE REDUCTION OF CARBONYL COMPOUNDS KANEKA CORP (JP) 2003-05-21 EP disclosed
US-6150567-A REACTING CARBONYL COMPOUND WITH ORGANOALUMINUM COMPOUND TO FORM AN ALCOHOL COMPOUND KANEKA CORPORATION (JP) 2000-11-21 US disclosed
EP-0827943-A1 PROCESSES FOR THE REDUCTION OF CARBONYL COMPOUNDS KANEKA CORPORATION (JP) 1998-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009564-A1 CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF CAPNS1, CAPN9, CAPN1 KLK5 4410/4885PSEN1 67/4885PSEN2 66/4885
US-11242312-B2 Dipeptidyl ketoamide meta-methoxyphenyl derivatives and uses thereof DPP4, DPP7, DPP3 KLK5 919/4885PSEN1 1452/4885PSEN2 2140/4885
US-20210317075-A1 DIPEPTIDYL KETOAMIDE META-METHOXYPHENYL DERIVATIVES AND USES THEREOF DPP4, DPP7, DPP3 KLK5 919/4885PSEN1 1452/4885PSEN2 2140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.